Literature DB >> 15752150

Genetic mechanisms of Rhesus box variation.

Franz F Wagner1, Joann M Moulds, Willy A Flegel.   

Abstract

BACKGROUND: The RHD gene is flanked by two highly homologous DNA segments of approximately 9000 bp, the upstream and downstream Rhesus boxes. In haplotypes with an RHD deletion, the fusion of the two Rhesus boxes generates the single-hybrid Rhesus box, the detection of which has been applied for RHD zygosity determination. Aberrant Rhesus boxes can confound this application and appear to be frequent among African individuals. STUDY DESIGN AND METHODS: A total of 5850 bp of the upstream and of the downstream Rhesus boxes were sequenced in 18 samples that were representative for all four D clusters and of the hybrid Rhesus boxes in four samples that were mistyped in assays for the hybrid Rhesus box.
RESULTS: The known differences between upstream and downstream Rhesus boxes were in part restricted to subsets of RHD alleles. Forty-six additional polymorphisms were detected and caused by single-nucleotide substitutions, short insertions, or deletions. Gene conversions were found in the upstream Rhesus boxes of RHDpsi, DAU-1, and DAU-3 and in the downstream Rhesus boxes of Ccdes, weak D type 4.1, type 4.2 (DAR), and DAU-0. Recombinations between haplotypes were likely in several alleles like DIII type 4. Four nonstandard hybrid Rhesus boxes were suggestive of multiple RHD deletion events.
CONCLUSION: There is considerable variation of Rhesus box sequences associated with distinct RHD alleles. RHD zygosity diagnostics in African persons is best based on quantitative polymerase chain reaction or amplification of the full-length hybrid Rhesus box. Because aberrant Rhesus boxes were observed among European persons, use of more than one method for hybrid Rhesus box detection may even be advisable in European persons.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15752150     DOI: 10.1111/j.1537-2995.2005.04339.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  10 in total

1.  RHCE*ceTI encodes partial c and partial e and is often in cis to RHD*DIVa.

Authors:  Connie M Westhoff; Sunitha Vege; Christine Halter Hipsky; Kim Hue-Roye; Tamara Copeland; Randall W Velliquette; Trina Horn; Christine Lomas-Francis; Marion E Reid
Journal:  Transfusion       Date:  2012-07-13       Impact factor: 3.157

2.  The DAU cluster: a comparative analysis of 18 RHD alleles, some forming partial D antigens.

Authors:  Kshitij Srivastava; Helene Polin; Sherry Lynne Sheldon; Franz Friedrich Wagner; Christoph Grabmer; Christian Gabriel; Gregory Andrew Denomme; Willy Albert Flegel
Journal:  Transfusion       Date:  2016-08-02       Impact factor: 3.157

3.  It's time to phase in RHD genotyping for patients with a serologic weak D phenotype. College of American Pathologists Transfusion Medicine Resource Committee Work Group.

Authors:  S Gerald Sandler; Willy A Flegel; Connie M Westhoff; Gregory A Denomme; Meghan Delaney; Margaret A Keller; Susan T Johnson; Louis Katz; John T Queenan; Ralph R Vassallo; Clayton D Simon
Journal:  Transfusion       Date:  2014-12-01       Impact factor: 3.157

4.  Transfusion support during childbirth for a woman with anti-U and the RHD*weak D type 4.0 allele.

Authors:  Q Yin; K Srivastava; D G Brust; W A Flegel
Journal:  Immunohematology       Date:  2021-03

5.  Validated Reference Panel from Renewable Source of Genomic DNA Available for Standardization of Blood Group Genotyping.

Authors:  Evgeniya Volkova; Emilia Sippert; Meihong Liu; Teresita Mercado; Gregory A Denomme; Orieji Illoh; Zhugong Liu; Maria Rios
Journal:  J Mol Diagn       Date:  2019-03-12       Impact factor: 5.568

6.  Accurate long-read sequencing allows assembly of the duplicated RHD and RHCE genes harboring variants relevant to blood transfusion.

Authors:  Zhe Zhang; Hyun Hyung An; Sunitha Vege; Taishan Hu; Shiping Zhang; Timothy Mosbruger; Pushkala Jayaraman; Dimitri Monos; Connie M Westhoff; Stella T Chou
Journal:  Am J Hum Genet       Date:  2021-12-29       Impact factor: 11.043

7.  Paternal RHD zygosity determination in Tunisians: evaluation of three molecular tests.

Authors:  Narjes Kacem; Saloua Jemni-Yacoub; Jacques Chiaroni; Pascal Bailly; Monique Silvy
Journal:  Blood Transfus       Date:  2014-06-19       Impact factor: 3.443

8.  The Significance of RHD Genotyping and Characteristic Analysis in Chinese RhD Variant Individuals.

Authors:  Yanling Ying; Jingjing Zhang; Xiaozhen Hong; Xianguo Xu; Ji He; Faming Zhu
Journal:  Front Immunol       Date:  2021-11-12       Impact factor: 7.561

Review 9.  DEL in China: the D antigen among serologic RhD-negative individuals.

Authors:  Qinan Yin; Willy Albert Flegel
Journal:  J Transl Med       Date:  2021-10-20       Impact factor: 5.531

10.  Prevalence of RhD status and clinical application of non-invasive prenatal determination of fetal RHD in maternal plasma: a 5 year experience in Cyprus.

Authors:  Thessalia Papasavva; Pete Martin; Tobias J Legler; Marios Liasides; George Anastasiou; Agathoklis Christofides; Tasos Christodoulou; Sotos Demetriou; Prokopis Kerimis; Charis Kontos; George Leontiades; Demetris Papapetrou; Telis Patroclos; Marios Phylaktou; Nikos Zottis; Eleni Karitzie; Eleni Pavlou; Petros Kountouris; Barbera Veldhuisen; Ellen van der Schoot; Marina Kleanthous
Journal:  BMC Res Notes       Date:  2016-04-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.